Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 116.835 USD -1.43%
Market Cap: 5.7B USD

Intrinsic Value

The intrinsic value of one AXSM stock under the Base Case scenario is 136.362 USD. Compared to the current market price of 116.835 USD, Axsome Therapeutics Inc is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AXSM Intrinsic Value
136.362 USD
Undervaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Axsome Therapeutics Inc

AXSM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AXSM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Axsome Therapeutics Inc
NASDAQ:AXSM
US
Pharmaceuticals
Market Cap
5.7B USD
IPO
Nov 19, 2015
US
Pharmaceuticals
Market Cap
5.7B USD
IPO
Nov 19, 2015
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AXSM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Axsome Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Axsome Therapeutics Inc

Current Assets 485.1m
Cash & Short-Term Investments 315.4m
Receivables 142m
Other Current Assets 27.7m
Non-Current Assets 83.4m
PP&E 6m
Intangibles 58.9m
Other Non-Current Assets 18.5m
Efficiency

Free Cash Flow Analysis
Axsome Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Axsome Therapeutics Inc

Revenue
385.7m USD
Cost of Revenue
-33.3m USD
Gross Profit
352.4m USD
Operating Expenses
-633m USD
Operating Income
-280.6m USD
Other Expenses
-6.7m USD
Net Income
-287.2m USD
Fundamental Scores

AXSM Profitability Score
Profitability Due Diligence

Axsome Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROE is Increasing
Exceptional 1-Year Revenue Growth
29/100
Profitability
Score

Axsome Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

AXSM Solvency Score
Solvency Due Diligence

Axsome Therapeutics Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
33/100
Solvency
Score

Axsome Therapeutics Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AXSM Price Targets Summary
Axsome Therapeutics Inc

Wall Street analysts forecast AXSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXSM is 180.158 USD with a low forecast of 149.48 USD and a high forecast of 222.6 USD.

Lowest
Price Target
149.48 USD
28% Upside
Average
Price Target
180.158 USD
54% Upside
Highest
Price Target
222.6 USD
91% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Axsome Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AXSM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AXSM Insider Trading
Buy and sell transactions by insiders

AXSM News

Other Videos
What is the Intrinsic Value of one AXSM stock?

The intrinsic value of one AXSM stock under the Base Case scenario is 136.362 USD.

Is AXSM stock undervalued or overvalued?

Compared to the current market price of 116.835 USD, Axsome Therapeutics Inc is Undervalued by 14%.

Back to Top